Circumferential and focal radiofrequency ablation for the treatment of Barrett's esophagus

Expert Review of Gastroenterology and Hepatology

Volumn 2, Issue 5, 2008, Pages 627-634

  Roorda, Andrew K ^a   Triadafilopoulos, George ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Barrett's esophagus; Circumferential ablation; Esophageal adenocarcinoma; Focal ablation; High grade dysplasia; Intestinal metaplasia; Low grade dysplasia; Radiofrequency ablation

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTIEMETIC AGENT; CODEINE; ESOMEPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; SUCRALFATE;

ALGORITHM; ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CHEMOPROPHYLAXIS; CHROMOENDOSCOPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG MEGADOSE; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INTERVENTION STUDY; INTESTINE METAPLASIA; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PREVALENCE; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; HUMANS; RISK FACTORS;

EID: 55349094647     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/17474124.2.5.627     Document Type: Article

References (24)

1. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125, 1670-1677 (2003).
2. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123, 636-639 (2002).
3. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am. J. Gastroenterol. 101, 1178-1182 (2006).
4. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119, 333-338 (2000).
5. Buttar NS, Wang KK, Sebo TJ et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120, 1630-1639 (2001).
6. Overholt BF, Lightdale CJ, Wang KK et al. Phorodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc. 62, 488-498 (2005).
7. Reid BJ, Levine DS, Longton G et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol. 95, 1669-1676 (2000).
8. Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120, 1607-1619 (2001).
9. Rastogi A, Puli S, El-Serag HB et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc. 67, 394-398 (2008).
10. Wolfsen HC, Utley DS, Peters JH. In: Shackelford's Surgery of the Alimentary Tract. 6th Edition. Yeo CJ, Dempsey DT, Klein AS, Pemberton JH, Peters JH (Eds). Saunders Elsevier, PA, USA 365-373, (2007).
11. Ganz RA, Utley DS, Stern RA et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc. 60, 1002-1010 (2004).
12. Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg. Endosc. 20, 125-130 (2006).
13. Smith CD, Bejarano PA, Melvin WS et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc. 21, 560-569 (2007).
14. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastroimest. Endosc. 65, 185-195 (2007).
15. Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett's esophagus: a mukicenter study with 2.5 year follow-up. Gastrointest. Endosc. DOI:10.1016/j. gie.2008.03.008 (2008) (Epub ahead of print).
16. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis. Esophagus 20, 516-522 (2007).
17. Ganz RA, Overhok BF, Sharma VK et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest. Endosc. 68(1), 35-40 (2008).
18. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 40(5), 380-387 (2008).
19. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 40(5), 359-369 (2008).
20. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40(5), 370-379 (2008).
21. Finkelstein SD, Lyday WD. The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus. Gastroenterology 134(4),A436 (2008).
22. Gondrie JJ, Rygiel AM, Sgndermeijer C et al. Balloon-based circumferential ablation: followed by focal ablation of Barrett's esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology 132(Suppl. 1), A64 (2007).
23. Das A, Wells CD, Fleischer DE et al. Combined modality (circumferential and focal) ablative therapy is a cost-effective (CE) management for non-dysplastic Barrett's esophagus (NDBE). Gastrointest. Endosc. 65, AB151 (2007).
24. Inadomi JM, Madanick RD, Somsouk M et al. Radiofrequency ablation is more cost-effective than endoscopic surveillance or esophagectomy among patients with Barrett's esophagus and low-grade dysplasia. Gastroenterology 132 (Suppl. 1), A53 (2007).